These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19070795)

  • 61. Attenuating effect of kaempferol on neoplastic growth in different urological malignancies.
    Kapoor S
    Biomed Pharmacother; 2018 Aug; 104():848. PubMed ID: 29566992
    [No Abstract]   [Full Text] [Related]  

  • 62. Targeting the Immune system and Epigenetic Landscape of Urological Tumors.
    Lobo J; Jerónimo C; Henrique R
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012885
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surgical margins following urological cancer surgery and clinical outcomes--does the United States need regional centralization of cancer care?
    Lowrance WT
    J Urol; 2010 Jun; 183(6):2126-7. PubMed ID: 20399470
    [No Abstract]   [Full Text] [Related]  

  • 64. A systematic review of nanocarriers for treatment of urologic cancers.
    Wang AJY; Yan C; Reike MJ; Black PC; Contreras-Sanz A
    Urol Oncol; 2024 Apr; 42(4):75-101. PubMed ID: 38161104
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analytical cytology: its role in urological oncology.
    Tanke HJ; Ploem JS; Jonas U
    Prog Clin Biol Res; 1984; 153():39-48. PubMed ID: 6382284
    [No Abstract]   [Full Text] [Related]  

  • 66. [Prospects 2007 in vesical pathology. Introduction].
    Allory Y; Compérat E; Mazerolle C; Sibony M
    Ann Pathol; 2008 Sep; 28(4):270-1. PubMed ID: 18928864
    [No Abstract]   [Full Text] [Related]  

  • 67. [How do metastases of urological tumors develop?].
    Rose M; Knüchel R
    Urologe A; 2014 Jun; 53(6):802-16. PubMed ID: 24824464
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urological implications of cyclophosphamide and ifosfamide.
    Lawson M; Vasilaras A; De Vries A; Mactaggart P; Nicol D
    Scand J Urol Nephrol; 2008; 42(4):309-17. PubMed ID: 18781541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent experiences using quality of life assessment tools in the treatment of patients with urological malignancies.
    Gerharz EW
    Urol Oncol; 2005; 23(3):184-5. PubMed ID: 15907719
    [No Abstract]   [Full Text] [Related]  

  • 70. Corticosteroid-induced chemotherapy resistance in urological cancers.
    Zhang C; Mattern J; Haferkamp A; Pfitzenmaier J; Hohenfellner M; Rittgen W; Edler L; Debatin KM; Groene E; Herr I
    Cancer Biol Ther; 2006 Jan; 5(1):59-64. PubMed ID: 16294015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Proceedings of the 102nd Congress of French Urology Association (AFU), 2008. Metastasis from urologic malignancies].
    Prog Urol; 2008 Nov; 18 Suppl 7():S141-436. PubMed ID: 19480066
    [No Abstract]   [Full Text] [Related]  

  • 72. Melatonin and urological cancers: a new therapeutic approach.
    Mehrzadi MH; Hosseinzadeh A; Juybari KB; Mehrzadi S
    Cancer Cell Int; 2020; 20():444. PubMed ID: 32943992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Grading of urologic tumors: is it still useful?
    Algaba F
    Int J Surg Pathol; 2010 Jun; 18(3 Suppl):112S-117S. PubMed ID: 20484274
    [No Abstract]   [Full Text] [Related]  

  • 74. Flashes of light and floaters: an unusual presentation of urothelial carcinoma.
    Maharaj S; Seegobin K; Shaikh M; Rana F
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30158265
    [No Abstract]   [Full Text] [Related]  

  • 75. [Molecular staging in urologic tumors. From wish to reality].
    Gelabert Mas A; Carles Galcerán J
    Actas Urol Esp; 1997 Jun; 21(6):533-9. PubMed ID: 9412186
    [No Abstract]   [Full Text] [Related]  

  • 76. [Rare urological tumors].
    Weining C; Roth S; Hertle L
    Krankenpfl J; 1996 Apr; 34(4):128-35. PubMed ID: 8716053
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunotherapy in urological malignancies: can you take your knowledge to the next level?
    Davis JW
    BJU Int; 2016 Oct; 118(4):491. PubMed ID: 27625327
    [No Abstract]   [Full Text] [Related]  

  • 78. Cutaneous metastasis: An unusual presenting feature of urologic malignancies.
    Menon AR; Thomas AS; Suresh N; Shashidhar SM
    Urol Ann; 2016; 8(3):377-80. PubMed ID: 27453667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Re: Open clinical uro-oncology trials in Canada.
    Morales A
    Can J Urol; 2007 Oct; 14(5):3723; author reply 3723. PubMed ID: 17949532
    [No Abstract]   [Full Text] [Related]  

  • 80. [Metastasized urological malignancies : Is resection of the primary tumor or destruction using alternative procedures worthwhile?].
    Stief CG; Rübben H
    Urologe A; 2017 May; 56(5):563. PubMed ID: 28337502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.